电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant IL2RA (Daclizumab Biosimilar) 抗体

The Mammalian Cells 单克隆 anti-IL2RA (Daclizumab Biosimilar) antibody (ABIN7487796) specifically detects IL2RA (Daclizumab Biosimilar) in ELISA. The antibody is reactive with 人 samples.
产品编号 ABIN7487796
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant IL2RA (Daclizumab Biosimilar) 抗体 (ABIN7487796)

抗原

IL2RA (Daclizumab Biosimilar)

抗体类型

Recombinant Antibody

适用

  • 6
  • 2
  • 2

宿主

  • 2
  • 2
  • 1
  • 1
Mammalian Cells

克隆类型

  • 3
  • 3
单克隆

标记

  • 6
This IL2RA (Daclizumab Biosimilar) antibody is un-conjugated

应用范围

  • 5
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA

质量等级

Research Grade
  • Expression System

    Mammalian cells

    原理

    Daclizumab Biosimilar - Anti-IL2RA mAb

    产品特性

    Antibody Type: IgG1-kappa

    纯化方法

    Recombinant antibody expressed in mammalien cells and purified.

    亚型

    IgG1 kappa
  • 限制

    仅限研究用
  • 缓冲液

    PBS pH 7.5

    储存条件

    -80 °C

    储存方法

    store at -80°C
  • 抗原

    IL2RA (Daclizumab Biosimilar)

    物质类

    Biosimilar

    背景

    BIIB019,DAC HYP
    Daclizumab is a humanized IgG1 monoclonal antibody that binds to human interleukin 2 receptor (anti-Tac or anti-CD25)and composed of human >90%) and murine (10%) antibody sequences. The human sequence is derived from the constant domain of human IgG1 and the variable framework region of Eu myeloma antibody. The murine part was taken from the complementarity-determining regions of a murine anti-Tac antibody. Daclizumab has been used for preventing acute organ rejection in de novo allogeneic kidney transplantation when used simultaneously with immunosuppressive regimens such as cyclosporine and corticosteroid and in the treatment of adult patients with relapsing multiple sclerosis. These trademarks were Zenapax and Zimbryta, respectively.

    CAS-编号

    152923-56-3
You are here: